Strategic healthcare M&A rebounded in 2021 from a down year in pandemic-ravaged 2020, with volume up 16% and total deal value rising by 44%, to $440 billion, Bain & Company reports. The year 2021 brought with it a return to pre-pandemic trends across all five sectors: pharmaceuticals, medtech, payers, providers, and healthcare services. What’s different this time, though, is that the cost of acquisitions has become dramatically more expensive in most areas, with deal multiples reaching the highest level in decades. Paying for these inflated multiples requires companies to get more creative in their deal theses and focus on better execution to deliver on deal value. Here’s what the best acquirers are doing. Read more.
Related Posts
Behavioral Health Drove Largest Share of Telehealth Visits in 2021
Behavioral is the only segment of the health care sector where telehealth is a substitute for in-person care, according to a new report.
March 7, 2022
Fertility Support Startups Banked $345M in 2021; Here’s Why the Business of Family Planning is Booming
Family planning has become fertile ground, pun intended, for healthcare startups.
May 18, 2022
Senior Living Construction Rebound Begins, Capital Sources Eager But Cautious
After a halt in the development and construction of new projects in senior housing during the pandemic, growth is back.
November 29, 2021
Managing Oncology Practice Revenue in the Face of Rising Healthcare Costs and Regulatory Burden
VMG Health experts explore the typical reimbursement concerns for oncology practices, including managing the revenue cycle, proper Electronic Health Record (EHR) management, and policy concerns related to value-based care trends.
May 18, 2023